GlassScriptPhysician profile
Kimberly S Brown
NPI 1205829009
$11,216.08
in general payments reported to CMS, 2019-2025
17 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,333 · 2020: $358 · 2021: $577 · 2022: $1,540 · 2023: $802 · 2024: $401 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,077 · Travel and Lodging: $331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,076.80 |
| Travel and Lodging | $331.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,944.47 | 2019-2025 | Avs Navigator, Xia 3, Tritanium |
| Medical Device Business Services, INC. | $1,624.29 | 2019 | |
| Depuy Synthes Sales INC. | $544.22 | 2019-2021 | |
| Organogenesis INC. | $287.63 | 2020-2023 | Puraply |
| Astrazeneca Pharmaceuticals LP | $228.18 | 2023-2024 | Andexxa |
| Medtronic, INC. | $98.18 | 2025 | O-Arm |
| Djo, LLC | $94.33 | 2019-2025 | Cmf |
| Novocure INC. | $89.92 | 2020-2021 | |
| Sanara Medtech INC. | $74.55 | 2023-2025 | Celleraterx, Celleraterx |
| Baxter Healthcare | $67.54 | 2022 | |
| Integra Lifesciences Corporation | $44.20 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $32.52 | 2022 | |
| Zimmer Biomet Holdings, INC. | $22.27 | 2019 | |
| Biogen, INC. | $19.01 | 2021 | |
| Portola Pharmaceuticals, LLC | $18.29 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $14.03 | 2024 | Anastoclip Gc 8cm (Medium) |
| Abbvie INC. | $12.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.